| RS2069548 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS2069560803 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2069566 |
TG
|
Health Risk |
Pathogenic |
Iodotyrosyl coupling defect, Autoimmune thyroid disease |
| RS2069578995 |
SOCS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Systemic lupus erythematosus, AUTOINFLAMMATORY SYNDROME |
| RS2069579242 |
SOCS1
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome with immunodeficiency, Autoinflammatory syndrome with immunodeficiency |
| RS2069582666 |
NBEA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2069582817 |
NBEA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2069586831 |
SOCS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Systemic lupus erythematosus, AUTOINFLAMMATORY SYNDROME |
| RS2069587477 |
SOCS1
|
Health Risk |
Pathogenic |
Autoimmune hemolytic anemia, Autoimmune thrombocytopenia |
| RS2069590640 |
NBEA
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2069591720 |
NBEA
|
Health Risk |
Likely pathogenic |
— |
| RS2069594174 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069601265 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069601882 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069602426 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069602711 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069603045 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069603579 |
NF1
|
Health Risk |
Pathogenic |
NF1-related disorder, Neurofibromatosis |
| RS2069605987 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069606043 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069606635 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069607664 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069655229 |
MAPKAPK5
|
Health Risk |
Pathogenic |
Neurocardiofaciodigital syndrome, Neurocardiofaciodigital syndrome |
| RS2069660959 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2069668717 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069669492 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069670110 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069670563 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069670885 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069671270 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069671730 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069671900 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069681044 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069681259 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069681958 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069682584 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069683635 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069684176 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069684411 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069687169 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069687450 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069687965 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069689101 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069689307 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069690617 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069691007 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069691055 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069691114 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069691466 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069704009 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069704188 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069704625 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069704915 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069705203 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069705362 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069705474 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069706454 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS2069707503 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069707755 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069708160 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069709 |
IFNG
|
Health Risk |
Pathogenic |
Acquired immunodeficiency syndrome, rapid progression to |
| RS2069709336 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069716520 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2069717157 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069717621 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069717916 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069718249 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069718437 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069718829 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069719445 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2069724056 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069724442 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069724582 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069724925 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069724967 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069725054 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069725866 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069727121 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069727438 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS2069727641 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069728377 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS2069729948 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2069742393 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069742475 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069742524 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069742717 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069743106 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069743252 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069743464 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069743547 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069743612 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069744859 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069745140 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069745354 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069778929 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2069779430 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2069789572 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069790028 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069790360 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069790543 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |